[EN] NOVEL BENZYL SULFONAMIDE COMPOUNDS USEFUL AS MOGAT-2 INHIBITORS [FR] NOUVEAUX COMPOSÉS DE BENZYLSULFONAMIDE UTILES EN TANT QU'INHIBITEURS DE MOGAT-2
[EN] NOVEL BENZYL SULFONAMIDE COMPOUNDS USEFUL AS MOGAT-2 INHIBITORS [FR] NOUVEAUX COMPOSÉS DE BENZYLSULFONAMIDE UTILES EN TANT QU'INHIBITEURS DE MOGAT-2
NOVEL BENZYL SULFONAMIDE COMPOUNDS USEFUL AS MOGAT-2 INHIBITORS
申请人:ELI LILLY AND COMPANY
公开号:US20150284404A1
公开(公告)日:2015-10-08
The present invention provides compounds of Formula I. Wherein R1, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds.
Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors
申请人:Eli Lilly and Company
公开号:US09416138B2
公开(公告)日:2016-08-16
The present invention provides compounds of Formula I. Wherein R1, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds.
[EN] NOVEL BENZYL SULFONAMIDE COMPOUNDS USEFUL AS MOGAT-2 INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS DE BENZYLSULFONAMIDE UTILES EN TANT QU'INHIBITEURS DE MOGAT-2
申请人:LILLY CO ELI
公开号:WO2014074365A1
公开(公告)日:2014-05-15
The present invention provides compounds of Formula I. Wherein Rl, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds.